The assembly of the polyketide backbone of rifamycin B on the type I rifamy
cin polyketide synthase (PKS), encoded by the rifA-rifE genes, is terminate
d by the product of the rifF gene, an amide synthase that releases the comp
leted undecaketide as its macrocyclic lactam. Inactivation of rifE gives a
rifamycin B nonproducing mutant that still accumulates a series of linear p
olyketides ranging from the tetra- to a decaketide, also detected in the wi
ld type, demonstrating that the PKS operates in a processive manner. Disrup
tions of the rifD module 8 and rifE module 9 and module 10 genes also resul
t in accumulation of such linear polyketides as a consequence. of premature
termination of polyketide assembly. Whereas the tetraketide carries an unm
odified aromatic chromophore, the penta- through decaketides have undergone
oxidative cyclization to the naphthoquinone, suggesting that this modifica
tion occurs during, not after, PKS assembly. The structure of one of the ac
cumulated compounds together with O-18 experiments suggests that this oxida
tive cyclization produces an 8-hydroxy-7,8-dihydronaphthoquinone structure
that, after the stage of proansamycin X, is dehydrogenated to an 8-hydroxyn
aphthoquinone.